why choose us

First received: January 26, 2023

Clinical Trial: Quantitative-imaging in Cardiac Transthyretin Amyloidosis

Study Status: Completed

Recruit Status: RECRUITING

Condition: ATTR-CM

Study Type: OBSERVATIONAL


Official Title: Quantitative-imaging in Cardiac Transthyretin Amyloidosis

Brief Summary: Transthyretin amyloid cardiomyopathy (ATTR-CM), is a heart muscle disease that's stops the heart muscle working properly.With an ageing population, it is increasingly common but untreated, it has a poor prognosis.Several novel expensive treatments have become available, although we do not understand exactly how they work and why some patients respond, and others do not.The challenge is to develop better methods for monitoring the effects of these treatments, maximizing their benefits and cost-effectiveness.In…

Read more